MwanzoPRGO • NYSE
add
Perrigo Company PLC
Bei iliyotangulia
$ 25.06
Bei za siku
$ 25.03 - $ 25.57
Bei za mwaka
$ 23.14 - $ 33.46
Thamani ya kampuni katika soko
3.43B USD
Wastani wa hisa zilizouzwa
1.73M
Uwiano wa bei na mapato
-
Mgao wa faida
4.62%
Ubadilishanaji wa msingi
NYSE
Kwenye habari
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
(USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato | 1.14B | -1.61% |
Matumizi ya uendeshaji wa biashara | 117.10M | -64.85% |
Mapato halisi | -44.50M | -37.77% |
Kiwango cha faida halisi | -3.91 | -40.14% |
Mapato kwa kila hisa | 0.93 | 8.14% |
EBITDA | 349.10M | 93.84% |
Asilimia ya kodi ya mapato | 159.29% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
(USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 558.80M | -24.93% |
Jumla ya mali | 9.65B | -10.74% |
Jumla ya dhima | 5.33B | -11.80% |
Jumla ya hisa | 4.32B | — |
hisa zilizosalia | 136.46M | — |
Uwiano wa bei na thamani | 0.79 | — |
Faida inayotokana na mali | 6.45% | — |
Faida inayotokana mtaji | 7.59% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
(USD) | Des 2024info | Mabadiliko Tangu Mwaka Uliopita |
---|---|---|
Mapato halisi | -44.50M | -37.77% |
Pesa kutokana na shughuli | 312.60M | 49.78% |
Pesa kutokana na uwekezaji | -37.10M | -62.72% |
Pesa kutokana na ufadhili | -1.15B | -2,487.67% |
Mabadiliko halisi ya pesa taslimu | -904.70M | -691.31% |
Mtiririko huru wa pesa | 517.39M | 45.97% |
Kuhusu
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
1887
Tovuti
Wafanyakazi
8,379